Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Harris & Harris Group Notes Amgen to Acquire BioVex

Abstract:
Harris & Harris Group, Inc. (NASDAQ: TINY) notes that Amgen and BioVex Group, Inc., today announced that the companies have entered into a definitive acquisition agreement under which Amgen has agreed to acquire BioVex Group, a privately held, venture-funded, biotechnology company headquartered in Woburn, Mass. BioVex Group is developing OncoVEXGM-CSF, a novel oncolytic vaccine in Phase 3 clinical development, that may represent a new approach to treating melanoma and head and neck cancer.

Harris & Harris Group Notes Amgen to Acquire BioVex

New York, NY | Posted on January 25th, 2011

Under terms of the agreement, Amgen will pay up to $1 billion: $425 million in cash at closing and up to $575 million in additional payments upon the achievement of certain regulatory and sales milestones. The transaction has been approved by the boards of directors of each company. It is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2011.

Following the completion of the transaction, BioVex Group will become a wholly owned subsidiary of Amgen.

Harris & Harris Group is an investor in privately held BioVex Group. Harris & Harris Group made its initial investment in BioVex Group in September 2007.

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2009, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the website www.HHVC.com has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.

####

About Harris & Harris Group
Harris & Harris Group is a publicly traded venture capital company that invests in nanotechnology and microsystems. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com.

For more information, please click here

Copyright © Harris & Harris Group

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Machine learning speeds modeling of experiments aimed at capturing fusion energy on Earth May 17th, 2019

Manipulating atoms one at a time with an electron beam: New method could be useful for building quantum sensors and computers May 17th, 2019

New surface treatment could improve refrigeration efficiency: A slippery surface for liquids with very low surface tension promotes droplet formation, facilitating heat transfer May 17th, 2019

Generating high-quality single photons for quantum computing: New dual-cavity design emits more single photons that can carry quantum information at room temperature May 17th, 2019

Nanomedicine

Better microring sensors for optical applications May 10th, 2019

New efficient way to engineer nanostructures mimicking natural immune response complexes: Novel method to engineer large multi-antibody-like nanostructures using DNA nanotechnology; the results demonstrate the potential for assembly of multiple proteins and also other materials t May 10th, 2019

Nanotubes enable travel of Huntington's protein: Rhes protein makes its own road to convey disease drivers May 10th, 2019

A cautionary tale for researchers working on selective drug delivery May 9th, 2019

Announcements

Machine learning speeds modeling of experiments aimed at capturing fusion energy on Earth May 17th, 2019

Manipulating atoms one at a time with an electron beam: New method could be useful for building quantum sensors and computers May 17th, 2019

New surface treatment could improve refrigeration efficiency: A slippery surface for liquids with very low surface tension promotes droplet formation, facilitating heat transfer May 17th, 2019

Generating high-quality single photons for quantum computing: New dual-cavity design emits more single photons that can carry quantum information at room temperature May 17th, 2019

Nanobiotechnology

New efficient way to engineer nanostructures mimicking natural immune response complexes: Novel method to engineer large multi-antibody-like nanostructures using DNA nanotechnology; the results demonstrate the potential for assembly of multiple proteins and also other materials t May 10th, 2019

Nanotubes enable travel of Huntington's protein: Rhes protein makes its own road to convey disease drivers May 10th, 2019

A cautionary tale for researchers working on selective drug delivery May 9th, 2019

Vaccine design can dramatically improve cancer immunotherapies: Effectiveness depends on molecular architecture and 3D presentation of components May 6th, 2019

Acquisitions/Mergers/Splits

VIS To Acquire GLOBALFOUNDRIES’ Fab 3E In Singapore February 1st, 2019

180 Degree Capital Corp.’s Portfolio Company, TheStreet, Inc., Agrees to Sell Its Institutional Business Units to Euromoney Institutional Investor PLC for $87.3 Million December 6th, 2018

Nanometrics Completes Acquisition of 4D Technology Corporation: The addition of Dynamic Interferometry® expands process control technology solutions November 16th, 2018

Bruker Announces Acquisition of Nanoindenting Leader Hysitron: Acquisition strengthens Bruker’s leading position in nanoanalysis and nanomechanical materials characterization January 24th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project